Tumor Markers

Overview

  • Proteins released by neoplasm into circulation
  • Tumor markers should be used to
    • confirm diagnosis
    • monitor therapeutic response
    • monitor tumor recurrence
    • NOT as a means to diagnose cancer in absence of physical examination of the tissue (e.g. biopsy)
Reproductive Cancer MarkersNormal FunctionDescription
PSA (Prostate-specific antigen)Liquefaction of semen Prostate carcinomaalso released with BPH and prostatitisincrease in bound PSA (as compared to free PSA) is suggestive of cancer
Prostatic acid phosphatase Prostate carcinoma
α-fetoprotein (AFP)Fetal albuminHepatocellular carcinomasNonseminomatous germ cell tumors of the testise.g. yolk sac tumor
β-hCGNormally released by placenta as a corpus luteum trophic hormoneHydatidiform molesChoriocarcinomasGestational trophoblastic tumors
CA-125Released by peritoneum with irritation (can be elevated in endometriosis)Ovarian Epithelial tumors
Miscellaneous Cancer Markers      Description
TRAP (Tartrate-resistant acid phosphatase)Hairy cell leukemia 
CA-19-9Pancreatic adenocarcinoma
ChromograninNeuroendocrine tumors
CalcitoninMedullary carcinoma of the thyroid
Multicancer Markers      Description
S-100Melanoma Neural tumorsAstrocytomas
Alkaline phosphataseMarker of bone formationosteoblastic metastases to bone (e.g. prostate)Paget’s disease of boneAlso released when bile ducts are damagedobstructive biliary disease
BombesinNeuroblastomaLung cancerGastric cancer
CEAColorectal cancerPancreatic cancer